Sharon Mates

Intra-Cellular Therapies, Inc. (ITCI)
     New York, NY
Total Compensation for Fiscal Year Ending in 2024: $13,305,510
Salary $936,236
Bonus $2,340,590
Value of Stock Awards $9,999,950
Value of Option Awards $0
Non-Equity Incentive Plan Compensation $0
Change in Pension Value and Deferred Compensation Earnings $0
All Other Compensation $28,734
Total $13,305,510
Intra-Cellular Therapies, Inc. disclosed its CEO pay was
61
times its median employee's pay for the fiscal year ending in 2024.
How Do You Compare?